Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Launch date
Employees
Market cap
$2.5m
Enterprise valuation
$129m (Public information from Sep 2024)
Share price
$0.0056 SRNE
San Diego California (HQ)
Authorizing premium user...